NCT00096590View on ClinicalTrials.gov

Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2004

Conditions
ThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Interventions
OTHER

coagulation study

OTHER

immunoenzyme technique

OTHER

laboratory biomarker analysis

OTHER

physiologic testing

PROCEDURE

study of high risk factors

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00096590 - Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter